Stoke Therapeutics Inc. (STOK)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
8.65
-0.27 (-3.03%)
At close: Jan 14, 2025, 3:59 PM
8.68
0.35%
After-hours Jan 14, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | 8.78M | 12.40M | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 3.54M | 2.23M | 1.93M | 450.00K | 214.00K | 113.00K |
Gross Profit | 8.78M | 8.87M | -2.23M | -1.93M | -450.00K | -214.00K | -113.00K |
Operating Income | -114.77M | -104.36M | -86.06M | -53.04M | -35.68M | -12.78M | -5.55M |
Interest Income | n/a | 3.12M | 120.00K | 744.00K | 3.35M | 270.00K | n/a |
Pretax Income | -104.70M | -101.07M | -85.81M | -52.24M | -32.33M | -12.52M | -5.56M |
Net Income | -104.70M | -93.11M | -84.71M | -50.61M | -28.52M | -12.52M | -5.56M |
Selling & General & Admin | 41.32M | 38.92M | 31.90M | 20.85M | 11.91M | 4.41M | 1.96M |
Research & Development | 82.23M | 77.84M | 54.17M | 32.20M | 23.76M | 8.37M | 3.60M |
Other Expenses | n/a | 167.00K | 140.00K | 57.00K | 2.00K | -10.00K | -4.00K |
Operating Expenses | 123.55M | 116.76M | 86.06M | 53.04M | 35.68M | 12.78M | 5.55M |
Interest Expense | n/a | 3.12M | 120.00K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 123.55M | 116.76M | 86.06M | 53.04M | 35.68M | 12.78M | 5.55M |
Income Tax | n/a | -7.96M | -1.09M | -1.63M | -3.80M | 260.00K | n/a |
Shares Outstanding (Basic) | 43.99M | 38.90M | 36.74M | 33.49M | 17.97M | 23.51M | 12.79M |
Shares Outstanding (Diluted) | 43.99M | 38.90M | 36.74M | 33.49M | 17.97M | 23.51M | 12.79M |
EPS (Basic) | -2.38 | -2.39 | -2.31 | -1.51 | -1.59 | -0.53 | -0.43 |
EPS (Diluted) | -2.38 | -2.39 | -2.31 | -1.51 | -1.59 | -0.53 | -0.43 |
EBITDA | -112.30M | -102.81M | -83.58M | -50.32M | -35.23M | -12.57M | -5.44M |
Depreciation & Amortization | 2.47M | 3.54M | 2.23M | 1.93M | 450.00K | 214.00K | 113.00K |